A technetium diagnostic aid used in renal function determination.
The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, atomic number 43, and atomic weight 98.91. All technetium isotopes are radioactive. Technetium 99m (m=metastable) which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years.
A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans.
A nontoxic radiopharmaceutical that is used in RADIONUCLIDE IMAGING for the clinical evaluation of hepatobiliary disorders in humans.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen.
A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms.
A radiopharmaceutical used extensively in cholescintigraphy for the evaluation of hepatobiliary diseases. (From Int Jrnl Rad Appl Inst 1992;43(9):1061-4)
A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation.
A technetium imaging agent used in renal scintigraphy, computed tomography, lung ventilation imaging, gastrointestinal scintigraphy, and many other procedures which employ radionuclide imaging agents.
Inorganic compounds that contain TECHNETIUM as an integral part of the molecule. Technetium 99m (m=metastable) is an isotope of technetium that has a half-life of about 6 hours. Technetium 99, which has a half-life of 210,000 years, is a decay product of technetium 99m.
Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents.
A trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.
A gamma-emitting RADIONUCLIDE IMAGING agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and MYOCARDIAL PERFUSION IMAGING. It has also been used to label leukocytes in the investigation of INFLAMMATORY BOWEL DISEASES.
A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.
A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.
The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.
Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)
Compounds that contain the radical R2C=N.OH derived from condensation of ALDEHYDES or KETONES with HYDROXYLAMINE. Members of this group are CHOLINESTERASE REACTIVATORS.
Pathologic inclusions occurring in erythrocytes.
Poly or pyrophosphates of tin. In conjunction with radioactive technetium these compounds are used as bone-scanning agents and in scintigraphy to diagnose myocardial and cerebral infarction.
Inorganic salts of phosphoric acid that contain two phosphate groups.
Pollutants, present in soil, which exhibit radioactivity.
Inorganic compounds that contain tin as an integral part of the molecule.
Compounds that contain the triphenylmethane aniline structure found in rosaniline. Many of them have a characteristic magenta color and are used as COLORING AGENTS.
A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.
Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms.
A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
'Sugar acids' are organic compounds derived from sugars through various processes, characterized by the presence of both a carboxyl group (-COOH) and a hydroxyl group (-OH) in their molecular structure, often found in food sources like fruits and used in industries such as food, pharmaceutical, and cosmetic.
Inorganic or organic compounds derived from phosphine (PH3) by the replacement of H atoms. (From Grant & Hackh's Chemical Dictionary, 5th ed)
Rhenium. A metal, atomic number 75, atomic weight 186.2, symbol Re. (Dorland, 28th ed)
Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios.
Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera.
Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE.

Value of captopril renal scintigraphy in hypertensive patients with renal failure. (1/140)

The aims of this study were to show the value of captopril renal scintigraphy for detecting a renovascular cause in hypertensive patients with renal failure and to assess the ability to predict the beneficial effect of revascularization on renal function. METHODS: Thirty-eight patients with renal failure (mean glomerular filtration rate = 35 mL/min) underwent renal scintigraphy after injection of 99mTc-mercaptoacetyltriglycine. Baseline scintigraphy was performed, and the test was repeated 24 h later after oral administration of 50 mg captopril given 60 min before the test. RESULTS: In 5 of 6 patients with a renovascular cause for renal failure, and 2 of 3 patients with a probable arterial pathology, scintigraphy had a high probability. The result was indeterminate in the other 2 patients. In 5 of 11 patients with negative arteriography and 14 of 18 patients with probable absence of renovascular pathology, we found a low probability of functional renal artery stenosis. Six revascularization procedures were performed and were predictive of a beneficial effect in 5 patients. Time of peak activity was an effective predictor in each case. CONCLUSION: In hypertensive patients with renal failure, captopril renal scintigraphy can detect hemodynamic dysfunction downstream from a renal artery stenosis and can predict the beneficial effect of revascularization in some cases.  (+info)

Evaluation of renal function from 99mTc-MAG3 renography without blood sampling. (2/140)

To develop a camera-based method for evaluating renal function with 99mTc-mercaptoacetyltriglycine (MAG3), we examined the relationship between various renogram parameters and 99mTc-MAG3 clearance. METHODS: Twenty-one patients underwent renal scintigraphy with 99mTc-MAG3. Eighty 3-s frames were obtained after the bolus injection of 250 MBq tracer, followed by the collection of 52 30-s frames. Regions of interest were drawn for the kidneys, perirenal background areas and subrenal background areas, and background-subtracted renograms were generated. Renal accumulation at 0.5-1.5, 0.5-2, 1-2, 1-2.5 and 1.5-2.5 min after tracer arrival in the kidney was calculated as area under the background-subtracted renogram, and percent renal uptake was obtained after correction for soft-tissue attenuation and injected dose. The slope of the renogram was determined for the same segments used in calculating area under the renogram, and slope index was computed as slope corrected for attenuation and injected dose. Percent renal uptakes and slope indices were correlated by linear regression analysis with 99mTc-MAG3 clearance measured using a single blood sampling method. RESULTS: Among the values of percent renal uptake, the value obtained at 1.5-2.5 min using the perirenal background correlated best with 99mTc-MAG3 clearance. The slope index at 0.5-1.5 or 0.5-2 min using the subrenal background provided better accuracy than percent renal uptake for predicting clearance. There were no substantial differences in the relative function of the right kidney between the methods using percent renal uptake and slope index. CONCLUSION: 99mTc-MAG3 clearance can be assessed with acceptable accuracy by a camera-based method. The method based on the slope of the renogram may replace the one based on the area under the renogram in evaluating renal function from 99mTc-MAG3 renograms.  (+info)

In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. (3/140)

In previous clinical studies, excellent visualization of tumor lesions has been observed with 131I-labeled monoclonal antibody (mAb) G250 in patients with renal cell carcinoma (RCC). In several cases, 131I-cG250 immunoscintigraphy disclosed tumor lesions that were not visualized by radiography or CT. To improve image quality, we aimed to develop a 99mTc-labeled mAb G250 preparation for radioimmunodetection of RCC. We studied in vitro stability, biodistribution and imaging potential of three 99mTc-labeled G250 preparations in nude mice with subcutaneous RCC xenografts.125I-G250 and the nonspecific mAb 131I-MN14 were used as control antibodies. METHODS: The mAb G250 was labeled with 99mTc according to three methods using: (a) S-hydrazinonicotinamide (HYNIC), (b) S-benzoylmercaptoacetyltriglycine (MAG3) and (c) a direct labeling method (Schwarz method). The stability of all preparations was tested in serum at 37 degrees C during 48 h. In addition, diethylenetriamine pentaacetic acid, cysteine and glutathione challenge assays were performed. RESULTS: All preparations showed good stability in serum during the 48-h incubation period. 99mTc-G250 (Schwarz) showed release of the radiolabel at a 100-fold or higher molar excess of cysteine and at a 10,000-fold or higher molar excess of glutathione. 99mTc-MAG3-G250 showed release of the radiolabel at a 10,000-fold molar excess of cysteine. 99mTc-HYNIC-G250 was stable under all conditions. Tumors were clearly visualized with all preparations. 99mTc-G250 (Schwarz) showed significantly lower blood levels (3.8 %ID/g) compared with all other preparations (11.2, 13.4 and 13.4 %ID/g for 99mTc-HYNIC-G250, 99mTc-MAG3-G250 and 125I-G250, respectively, 48 h postinjection). At 48-h postinjection, mean tumor uptake was very high with all mAb G250 preparations: 92.4 (99mTc-HYNIC-G250), 125.9 (99mTc-MAG3-G250), 29.4 (99mTc-G250 Schwarz) and 75.4 (125I-G250) %ID/g. Mean tumor uptake of the nonspecific 131I-MN14 mAb was 6.6 %ID/g. CONCLUSION: In this study, 99mTc-HYNIC-G250 showed excellent in vitro stability and tumor targeting. Moreover, this preparation could be labeled with high efficiency (>95%) at room temperature within 15 min. Therefore, 99mTc-HYNIC-G250 seems to be an ideal candidate for radioimmunodetection of RCC.  (+info)

Dynamic SPECT evaluation of renal plasma flow using technetium-99m MAG3 in kidney transplant patients. (4/140)

OBJECTIVE: The purpose of this study was to evaluate Patlak's graphic analysis method to determine renal plasma flow (RPF) in kidney transplants. METHODS: Dynamic SPECT was performed with 99mTc MAG3 in 12 patients. RPF was determined by both Patlak's graphic analysis method and Russell's method. Ventral, central and dorsal tomographic images of the transplanted kidney were reconstructed to estimate intrarenal distribution of renal plasma flow. RESULTS: The renal influx constant (Ku) calculated by Patlak's graphic analysis method was reproducible and correlated with both serum creatinine (r = -0.88, P < 0.001) and blood urea nitorogen levels (r = -0.82, P < 0.002). However, a significant difference was noted between the RPF values derived from Patlak's graphic analysis method and Russell's method. Ku was corrected by a factor calculated from raw and reconstructed data, and the resulting values were in fair agreement with those determined by Russell's method. CONCLUSION: These methods are useful in evaluating the function of transplanted kidneys.  (+info)

Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate. (5/140)

Recent literature has questioned whether 99mTc-mercaptoacetyltriglycine (MAG3) clearance measurements are reproducible enough for routine clinical monitoring of renal function. For many years, we have routinely followed the renal function of patients with spinal cord injuries using a combination of radionuclide imaging and clearance measurement. METHODS: In this study, we retrospectively review 1626 effective renal plasma flow (ERPF) measurements in 197 patients with paraplegia or quadriplegia performed over a 21-y period, using 131I-orthoiodohippurate (OIH) through 1990 and MAG3 since 1991. MAG3 clearance was divided by 0.53 to convert it to ERPF. Reproducibility was measured as pooled SD from the single-patient linear regression lines of ERPF versus time. RESULTS AND CONCLUSION: There was no significant difference between MAG3 (SD = 46 mL/min, n = 907) and OIH (SD = 52 mL/min, n = 719). The data were therefore combined to obtain the SD for a single ERPF measurement, which was 49 mL/min. The corresponding coefficient of variation was 8.5% of the mean value of 581 mL/min. In our experience, this is adequate for monitoring the renal function of these patients.  (+info)

Relative 99mTc-MAG3 renal uptake: reproducibility and accuracy. (6/140)

The aim of this study was to estimate the reproducibility and accuracy of 99mTc-mercaptoacetyltriglycine (MAG3) relative percentage uptake. METHODS: Reproducibility was evaluated on healthy volunteers who were submitted twice to a 99mTc-MAG3 renographic study, which used different uptake algorithms, different background corrections and different time intervals. Accuracy was evaluated in a group of patients with symmetrical or asymmetrical relative renal function, who underwent both 99mTc-dimercaptosuccinic acid (DMSA) and 99mTc-MAG3 studies, using the DMSA relative percentage uptake as a reference. RESULTS AND CONCLUSION: The methods that combined the best reproducibility and accuracy for estimating 99mTc-MAG3 left-to-right uptake ratio were the integral method, with subrenal or perirenal background correction, and the Patlak-Rutland plot. The use of the integral method without background correction introduced a systematic bias, whereas the slope method resulted in high variability. Therefore these methods cannot be recommended.  (+info)

A comparison of deconvolution and the Patlak-Rutland plot in renography analysis. (7/140)

Deconvolution and the Patlak-Rutland plot are two of the most commonly used methods for analyzing dynamic radionuclide renography. Both methods allow estimation of absolute and relative renal uptake of radiopharmaceutical and of its rate of transit through the kidney. METHODS: A theoretical comparison of uptake assessment by both techniques is made and a mathematical derivation of the relationship between mean transit time (MTT) and renal outflow efficiency (ROE) is presented. The validity of these theoretical findings was tested in a series of 120 renograms obtained using 99mTc-mercaptoacetyltriglycine (MAG3). RESULTS: The estimates of renal uptake obtained are theoretically equivalent. The renogram measurements confirmed this, because there was no significant systematic difference in relative counts obtained by the two methods. Absolute counts were significantly higher for the deconvolution measurements, but only by 2.0%. The SDs of the differences between the two techniques, expressed as a percentage of the mean, were 1.7% and 5.4% for relative and absolute counts, respectively. There was an inverse monotonic relationship between MTT and ROE. ROE evaluated at a particular time was shown to depend on absolute renal function. Measured values of MTT and ROE were consistent with the theoretical prediction. CONCLUSION: The two approaches to renogram analysis provide consistent parameters for both uptake and transit evaluation.  (+info)

F+0 diuresis renography in infants and children. (8/140)

The purpose of this study was to evaluate the feasibility of modifying diuresis renography by the simultaneous administration of 99mTc-mercaptoacetyltriglycine (MAG3) and furosemide in the investigation of hydronephrosis and hydroureteronephrosis in infants and children. Two parameters were assessed: the diuretic response in normal kidneys and the ability of the F+0 study to differentiate between renal obstruction and nonobstruction and to identify the level of obstruction in cases of renal obstruction. METHODS: Seventy-two patients (48 males, 24 females; age 2 d to 7 y; median age 6 wk) with sonographic diagnoses of hydronephrosis or hydroureteronephrosis were reviewed prospectively over a 3-y period. All patients had prior sonographic studies and micturating cystourethrography. Bladder catheterization was not routinely performed and was undertaken only if the child had suspected vesicoureteric junction (VUJ) obstruction or grade II or more vesicoureteric reflux. A weight-adjusted dose of 99mTc-MAG3 (maximum 200 MBq, minimum 20 MBq) and 1 mg/kg of furosemide (maximum 40 mg) were administered intravenously at the same time. Posterior imaging of the kidneys and bladder was performed for 20 min and followed by gravity-assisted drainage or imaging after voiding. All patients were followed-up for 6-12 mo, and the final diagnoses were based on either surgery or conservative management with repeated sonography or follow-up 99mTc-MAG3 studies (or both). The results of the F+0 diuresis renography were then compared with the final diagnoses. RESULTS: A renal unit was defined as a kidney and its ureter. There were 151 renal units with 1 patient having bilateral duplex kidneys, 6 patients having unilateral duplex kidneys and 1 patient having a solitary kidney. Fifty-five normal renal units and 96 abnormal renal units on the basis of sonographic findings were assessed. The furosemide clearance half-time for the 55 normal renal units was 1.3-6.3 min (mean 3.8 min). Of the 96 abnormal renal units, 53 were classified as nonobstructed and 43 were classified as obstructed. Of the 53 renal units classified as nonobstructed, there were 48 true-negative studies and 5 false-negative studies; of the 43 renal units classified as obstructed, there were 40 true-positive studies and 3 false-positive studies. The sensitivity was 88.9%, specificity was 94.1% and accuracy was 91.7%. The level of obstruction, either pelviureteric junction or VUJ, was also correctly identified. CONCLUSION: F+0 diuresis renography shows excellent diuretic responses in normal kidneys and is a valid method for the investigation of hydronephrosis and hydroureteronephrosis in infants and children.  (+info)

Technetium Tc 99m Mertiatide is a radiopharmaceutical used in nuclear medicine imaging procedures. It is a technetium-labeled compound, where the radioisotope technetium-99m (^99m^Tc) is bound to mercaptoacetyltriglycine (MAG3). The resulting complex is known as ^99m^Tc-MAG3 or Technetium Tc 99m Mertiatide.

This radiopharmaceutical is primarily used for renal function assessment, including evaluation of kidney blood flow, glomerular filtration rate (GFR), and detection of renal obstructions or other abnormalities. After intravenous administration, Technetium Tc 99m Mertiatide is rapidly excreted by the kidneys, allowing for visualization and quantification of renal function through gamma camera imaging.

It's important to note that the use of radiopharmaceuticals should be performed under the guidance of a qualified healthcare professional, as they involve the administration of radioactive materials for diagnostic purposes.

Technetium is not a medical term itself, but it is a chemical element with the symbol Tc and atomic number 43. However, in the field of nuclear medicine, which is a branch of medicine that uses small amounts of radioactive material to diagnose or treat diseases, Technetium-99m (a radioisotope of technetium) is commonly used for various diagnostic procedures.

Technetium-99m is a metastable nuclear isomer of technetium-99, and it emits gamma rays that can be detected outside the body to create images of internal organs or tissues. It has a short half-life of about 6 hours, which makes it ideal for diagnostic imaging since it decays quickly and reduces the patient's exposure to radiation.

Technetium-99m is used in a variety of medical procedures, such as bone scans, lung scans, heart scans, liver-spleen scans, brain scans, and kidney scans, among others. It can be attached to different pharmaceuticals or molecules that target specific organs or tissues, allowing healthcare professionals to assess their function or identify any abnormalities.

Technetium Tc 99m Diethyl-iminodiacetic Acid (Tc 99m DTPA) is a radiopharmaceutical agent used in medical imaging. It is a technetium-labeled compound, where the radioisotope technetium-99m is bound to diethyl-iminodiacetic acid (DTPA). This complex is used as a renal agent for performing nuclear medicine imaging studies to assess kidney function and structure.

Technetium-99m is a metastable isotope of technetium that emits gamma rays, making it suitable for medical imaging. When Tc 99m DTPA is injected into the patient's body, it is excreted primarily by the kidneys through glomerular filtration and tubular secretion. The gamma rays emitted by technetium-99m are detected by a gamma camera, which generates images of the distribution and excretion of the radiopharmaceutical within the kidneys. This information helps physicians evaluate kidney function, detect abnormalities such as obstructions or tumors, and monitor the effectiveness of treatments.

It is essential to handle and administer Tc 99m DTPA with care due to its radioactive nature, following proper safety guidelines and regulations to ensure patient and staff safety.

Technetium Tc 99m Lidofenin is a radiopharmaceutical used in nuclear medicine imaging procedures, specifically for hepatobiliary scintigraphy. It is a technetium-labeled compound, where the radioisotope technetium-99m (^99m^Tc) is bound to lidofenin, a liver-imaging agent.

The compound is used to assess the function and anatomy of the liver, gallbladder, and biliary system. After intravenous administration, Technetium Tc 99m Lidofenin is taken up by hepatocytes (liver cells) and excreted into the bile ducts and ultimately into the small intestine. The distribution and excretion of this radiopharmaceutical can be monitored using a gamma camera, providing functional information about the liver and biliary system.

It is essential to note that the use of Technetium Tc 99m Lidofenin should be under the guidance and supervision of healthcare professionals trained in nuclear medicine, as its administration and handling require specific expertise and safety measures due to the radioactive nature of the compound.

Technetium Tc 99m Sulfur Colloid is a radioactive tracer used in medical imaging procedures, specifically in nuclear medicine. It is composed of tiny particles of sulfur colloid that are labeled with the radioisotope Technetium-99m. This compound is typically injected into the patient's body, where it accumulates in certain organs or tissues, depending on the specific medical test being conducted.

The radioactive emissions from Technetium Tc 99m Sulfur Colloid are then detected by a gamma camera, which produces images that can help doctors diagnose various medical conditions, such as liver disease, inflammation, or tumors. The half-life of Technetium-99m is approximately six hours, which means that its radioactivity decreases rapidly and is eliminated from the body within a few days.

Technetium Tc 99m Medronate is a radiopharmaceutical agent used in nuclear medicine for bone scintigraphy. It is a technetium-labeled bisphosphonate compound, which accumulates in areas of increased bone turnover and metabolism. This makes it useful for detecting and evaluating various bone diseases and conditions, such as fractures, tumors, infections, and arthritis.

The "Tc 99m" refers to the radioisotope technetium-99m, which has a half-life of approximately 6 hours and emits gamma rays that can be detected by a gamma camera. The medronate component is a bisphosphonate molecule that binds to hydroxyapatite crystals in bone tissue, allowing the radiolabeled compound to accumulate in areas of active bone remodeling.

Overall, Technetium Tc 99m Medronate is an important tool in nuclear medicine for diagnosing and managing various musculoskeletal disorders.

Technetium Tc 99m Disofenin is not a medical condition, but rather a radiopharmaceutical used in diagnostic imaging. It is a radioactive tracer used in nuclear medicine scans, specifically for liver and biliary system imaging. The compound consists of the radioisotope Technetium-99m (Tc-99m) bonded to the pharmaceutical Disofenin.

The Tc-99m is a gamma emitter with a half-life of 6 hours, making it ideal for diagnostic imaging. When administered to the patient, the compound is taken up by the liver and excreted into the bile ducts and gallbladder, allowing medical professionals to visualize these structures using a gamma camera. This can help detect various conditions such as tumors, gallstones, or obstructions in the biliary system.

It's important to note that Technetium Tc 99m Disofenin is used diagnostically and not for therapeutic purposes. The radiation exposure from this compound is generally low and considered safe for diagnostic use. However, as with any medical procedure involving radiation, the benefits and risks should be carefully weighed and discussed with a healthcare professional.

Technetium Tc 99m Pyrophosphate (Tc-99m PYP) is a radiopharmaceutical agent used in nuclear medicine imaging, specifically myocardial perfusion imaging. It is a complex of technetium-99m, a metastable isotope of technetium, with pyrophosphate, a molecule that accumulates in damaged heart muscle tissue.

When injected into the patient's bloodstream, Tc-99m PYP is taken up by the heart muscle in proportion to its blood flow and the degree of damage or scarring (fibrosis). This allows for the detection and evaluation of conditions such as myocardial infarction (heart attack), cardiomyopathy, and heart transplant rejection.

The imaging procedure involves the injection of Tc-99m PYP, followed by the acquisition of images using a gamma camera, which detects the gamma rays emitted by the technetium-99m isotope. The resulting images provide information about the distribution and extent of heart muscle damage, helping physicians to make informed decisions regarding diagnosis and treatment planning.

Technetium Tc 99m Aggregated Albumin is a radiopharmaceutical preparation used in diagnostic imaging. It consists of radioactive technetium-99m (^99m^Tc) chemically bonded to human serum albumin, which has been aggregated to increase its size and alter its clearance from the body.

The resulting compound is injected into the patient's bloodstream, where it accumulates in the reticuloendothelial system (RES), including the liver, spleen, and bone marrow. The radioactive emission of technetium-99m can then be detected by a gamma camera, producing images that reflect the distribution and function of the RES.

This imaging technique is used to diagnose and monitor various conditions, such as liver disease, inflammation, or tumors. It provides valuable information about the patient's health status and helps guide medical decision-making.

Technetium Tc 99m Pentetate is a radioactive pharmaceutical preparation used as a radiopharmaceutical agent in medical imaging. It is a salt of technetium-99m, a metastable nuclear isomer of technetium-99, which emits gamma rays and has a half-life of 6 hours.

Technetium Tc 99m Pentetate is used in various diagnostic procedures, including renal imaging, brain scans, lung perfusion studies, and bone scans. It is distributed throughout the body after intravenous injection and is excreted primarily by the kidneys, making it useful for evaluating renal function and detecting abnormalities in the urinary tract.

The compound itself is a colorless, sterile, pyrogen-free solution that is typically supplied in a lead shielded container to protect against radiation exposure. It should be used promptly after preparation and handled with care to minimize radiation exposure to healthcare workers and patients.

Technetium compounds refer to chemical substances that contain the radioactive technetium (Tc) element. Technetium is a naturally rare element and does not have any stable isotopes, making it only exist in trace amounts in the Earth's crust. However, it can be produced artificially in nuclear reactors.

Technetium compounds are widely used in medical imaging as radioactive tracers in diagnostic procedures. The most common technetium compound is Technetium-99m (Tc-99m), which has a half-life of 6 hours and emits gamma rays that can be detected by external cameras. Tc-99m is often bound to various pharmaceuticals, such as methylene diphosphonate (MDP) or human serum albumin (HSA), to target specific organs or tissues in the body.

Technetium compounds are used in a variety of diagnostic procedures, including bone scans, lung perfusion scans, myocardial perfusion imaging, and brain scans. They provide valuable information about organ function, blood flow, and tissue metabolism, helping doctors diagnose various medical conditions such as cancer, heart disease, and bone fractures.

It is important to note that technetium compounds should only be used under the supervision of trained medical professionals due to their radioactive nature. Proper handling, administration, and disposal procedures must be followed to ensure safety and minimize radiation exposure.

Organotechnetium compounds are chemical substances that contain carbon-technetium bonds, where technetium is an element with the symbol Tc and atomic number 43. These types of compounds are primarily used in medical imaging as radioactive tracers due to the ability of technetium-99m to emit gamma rays. The organotechnetium compounds help in localizing specific organs, tissues, or functions within the body, making them useful for diagnostic purposes in nuclear medicine.

It is important to note that most organotechnetium compounds are synthesized from technetium-99m, which is generated from the decay of molybdenum-99. The use of these compounds requires proper handling and administration by trained medical professionals due to their radioactive nature.

I'm sorry for any confusion, but "Tin" does not have a medical definition. Tin is a chemical element with the symbol Sn and atomic number 50. It is a malleable, ductile, silvery-white post-transition metal. It is found in nature mainly as tin oxides and is obtained from the mineral cassiterite through mining and processing.

Tin has no known biological role in humans, animals, or plants, and it is not considered an essential nutrient. Small amounts of tin can be found in some foods and drinking water, but these levels are generally low and not considered harmful. High levels of tin can be toxic to the human body, causing symptoms such as nausea, vomiting, and diarrhea.

If you have any questions about a medical condition or treatment, I would recommend consulting with a healthcare professional for accurate information and guidance.

Technetium Tc 99m Exametazime is a radiopharmaceutical agent used in nuclear medicine imaging procedures. The compound consists of the radioisotope Technetium-99m (^99m^Tc) bonded to Exametazime, also known as HMPAO (hexamethylpropyleneamine oxime).

Once injected into the patient's bloodstream, Technetium Tc 99m Exametazime distributes evenly throughout the brain, crossing the blood-brain barrier and entering cells. The radioactive decay of Technetium-99m emits gamma rays that can be detected by a gamma camera, creating images of the brain's blood flow and distribution of the tracer.

This imaging technique is often used in cerebral perfusion studies to assess conditions such as stroke, epilepsy, or dementia, providing valuable information about regional cerebral blood flow and potential areas of injury or abnormality.

Technetium Tc 99m Sestamibi is a radiopharmaceutical compound used in medical imaging, specifically in myocardial perfusion scintigraphy. It is a technetium-labeled isonitrile chelate that is taken up by mitochondria in cells with high metabolic activity, such as cardiomyocytes (heart muscle cells).

Once injected into the patient's body, Technetium Tc 99m Sestamibi emits gamma rays, which can be detected by a gamma camera. This allows for the creation of images that reflect the distribution and function of the radiopharmaceutical within the heart muscle. The images can help identify areas of reduced blood flow or ischemia, which may indicate coronary artery disease.

The uptake of Technetium Tc 99m Sestamibi in other organs, such as the breast and thyroid, can also be used for imaging purposes, although its primary use remains in cardiac imaging.

Technetium Tc 99m Dimercaptosuccinic Acid (DMSA) is a radiopharmaceutical agent used in nuclear medicine imaging procedures. The compound is made up of the radioisotope Technetium-99m, which emits gamma rays that can be detected by a gamma camera, and dimercaptosuccinic acid, which binds to certain types of metal ions in the body.

In medical imaging, Technetium Tc 99m DMSA is typically used to visualize the kidneys and detect any abnormalities such as inflammation, infection, or tumors. The compound is taken up by the renal tubules in the kidneys, allowing for detailed images of the kidney structure and function to be obtained.

It's important to note that the use of Technetium Tc 99m DMSA should be under the supervision of a trained medical professional, as with any radiopharmaceutical agent, due to the radiation exposure involved in its use.

Radionuclide imaging, also known as nuclear medicine, is a medical imaging technique that uses small amounts of radioactive material, called radionuclides or radiopharmaceuticals, to diagnose and treat various diseases and conditions. The radionuclides are introduced into the body through injection, inhalation, or ingestion and accumulate in specific organs or tissues. A special camera then detects the gamma rays emitted by these radionuclides and converts them into images that provide information about the structure and function of the organ or tissue being studied.

Radionuclide imaging can be used to evaluate a wide range of medical conditions, including heart disease, cancer, neurological disorders, gastrointestinal disorders, and bone diseases. The technique is non-invasive and generally safe, with minimal exposure to radiation. However, it should only be performed by qualified healthcare professionals in accordance with established guidelines and regulations.

Sodium Pertechnetate Tc 99m is a radioactive pharmaceutical preparation used in medical diagnostic imaging. It is a technetium-99m radiopharmaceutical, where technetium-99m is a metastable nuclear isomer of technetium-99, which emits gamma rays and has a half-life of 6 hours. Sodium Pertechnetate Tc 99m is used as a contrast agent in various diagnostic procedures, such as imaging of the thyroid, salivary glands, or the brain, to evaluate conditions like inflammation, tumors, or abnormalities in blood flow. It is typically administered intravenously, and its short half-life ensures that the radiation exposure is limited.

Radiopharmaceuticals are defined as pharmaceutical preparations that contain radioactive isotopes and are used for diagnosis or therapy in nuclear medicine. These compounds are designed to interact specifically with certain biological targets, such as cells, tissues, or organs, and emit radiation that can be detected and measured to provide diagnostic information or used to destroy abnormal cells or tissue in therapeutic applications.

The radioactive isotopes used in radiopharmaceuticals have carefully controlled half-lives, which determine how long they remain radioactive and how long the pharmaceutical preparation remains effective. The choice of radioisotope depends on the intended use of the radiopharmaceutical, as well as factors such as its energy, range of emission, and chemical properties.

Radiopharmaceuticals are used in a wide range of medical applications, including imaging, cancer therapy, and treatment of other diseases and conditions. Examples of radiopharmaceuticals include technetium-99m for imaging the heart, lungs, and bones; iodine-131 for treating thyroid cancer; and samarium-153 for palliative treatment of bone metastases.

The use of radiopharmaceuticals requires specialized training and expertise in nuclear medicine, as well as strict adherence to safety protocols to minimize radiation exposure to patients and healthcare workers.

Oximes are a class of chemical compounds that contain the functional group =N-O-, where two organic groups are attached to the nitrogen atom. In a clinical context, oximes are used as antidotes for nerve agent and pesticide poisoning. The most commonly used oxime in medicine is pralidoxime (2-PAM), which is used to reactivate acetylcholinesterase that has been inhibited by organophosphorus compounds, such as nerve agents and certain pesticides. These compounds work by forming a bond with the phosphoryl group of the inhibited enzyme, allowing for its reactivation and restoration of normal neuromuscular function.

Erythrocyte inclusions refer to the presence of abnormal structures or substances within red blood cells (erythrocytes). These inclusions can be composed of various materials such as proteins, pigments, or foreign bodies. They may be seen in a variety of medical conditions and can provide important diagnostic clues.

Some examples of erythrocyte inclusions include:

1. Howell-Jolly bodies: small remnants of nuclear material left behind after the red blood cell matures. They are typically seen in individuals with an absent or nonfunctional spleen.
2. Heinz bodies: denatured hemoglobin that forms clumps within the red blood cells. They can be seen in conditions such as hemolytic anemia, G6PD deficiency, and exposure to certain drugs or toxins.
3. Pappenheimer bodies: aggregates of iron-containing proteins called ferritin or hemosiderin. They are typically seen in conditions associated with increased red blood cell destruction, such as thalassemia or lead poisoning.
4. Basophilic stippling: small, basophilic (blue-staining) granules within the red blood cells. They can be seen in various conditions, including lead poisoning, megaloblastic anemias, and certain inherited disorders.
5. Parasites: organisms such as malaria or babesia that infect and multiply within the red blood cells.

The detection of erythrocyte inclusions typically requires specialized testing, such as peripheral blood smears stained with specific dyes to highlight the abnormal structures. The presence and type of inclusions can help diagnose certain medical conditions and guide appropriate treatment.

I'm sorry for any confusion, but "Tin Polyphosphates" is not a recognized medical term or concept. It appears to be a chemical compound, specifically a polyphosphate complex of tin. Polyphosphates are chains of phosphate groups, and in this case, they are bound to a tin (Sn) atom.

Tin polyphosphates may have various industrial applications, such as flame retardants or corrosion inhibitors, but they do not have a specific relevance to medical definition. If you have any questions about the chemical properties or uses of tin polyphosphates in a non-medical context, I would recommend consulting a chemistry or materials science resource.

Diphosphates, also known as pyrophosphates, are chemical compounds that contain two phosphate groups joined together by an oxygen atom. The general formula for a diphosphate is P~PO3~2-, where ~ represents a bond. Diphosphates play important roles in various biological processes, such as energy metabolism and cell signaling. In the context of nutrition, diphosphates can be found in some foods, including milk and certain vegetables.

Radioactive soil pollutants refer to radioactive substances that contaminate and negatively impact the chemical, physical, and biological properties of soil. These pollutants can arise from various sources such as nuclear accidents, industrial activities, agricultural practices, and military testing. They include radionuclides such as uranium, plutonium, cesium-137, and strontium-90, among others.

Exposure to radioactive soil pollutants can have serious health consequences for humans and other living organisms. Direct contact with contaminated soil can result in radiation exposure, while ingestion or inhalation of contaminated soil particles can lead to internal radiation exposure. This can increase the risk of cancer, genetic mutations, and other health problems.

Radioactive soil pollutants can also have negative impacts on the environment, such as reducing soil fertility, disrupting ecosystems, and contaminating water sources. Therefore, it is essential to monitor and regulate radioactive soil pollution to protect human health and the environment.

Tin compounds refer to chemical substances that contain tin (Sn) combined with one or more other elements. Tin can form various types of compounds, including oxides, sulfides, halides, and organometallic compounds. These compounds have different properties and uses depending on the other element(s) they are combined with.

For example:

* Tin (IV) oxide (SnO2) is a white powder used as an opacifying agent in glass and ceramics, as well as a component in some types of batteries.
* Tin (II) sulfide (SnS) is a black or brown solid used in the manufacture of some types of semiconductors.
* Tin (IV) chloride (SnCl4) is a colorless liquid used as a catalyst in the production of polyvinyl chloride (PVC) and other plastics.
* Organotin compounds, such as tributyltin (TBT), are used as biocides and antifouling agents in marine paints. However, they have been found to be toxic to aquatic life and are being phased out in many countries.

Rosaniline dyes are a type of basic dye that were first synthesized in the late 19th century. They are named after rosaniline, which is a primary chemical used in their production. Rosaniline dyes are characterized by their ability to form complexes with metal ions, which can then bind to proteins and other biological molecules. This property makes them useful as histological stains, which are used to highlight specific structures or features within tissues and cells.

Rosaniline dyes include a range of different chemicals, such as methyl violet, crystal violet, and basic fuchsin. These dyes are often used in combination with other staining techniques to provide contrast and enhance the visibility of specific cellular components. For example, they may be used to stain nuclei, cytoplasm, or other structures within cells, allowing researchers and clinicians to visualize and analyze tissue samples more effectively.

It's worth noting that some rosaniline dyes have been found to have potential health hazards, particularly when used in certain forms or concentrations. Therefore, it's important to follow proper safety protocols when handling these chemicals and to use them only under the guidance of trained professionals.

Emission-Computed Tomography, Single-Photon (SPECT) is a type of nuclear medicine imaging procedure that generates detailed, three-dimensional images of the distribution of radioactive pharmaceuticals within the body. It uses gamma rays emitted by a radiopharmaceutical that is introduced into the patient's body, and a specialized gamma camera to detect these gamma rays and create tomographic images. The data obtained from the SPECT imaging can be used to diagnose various medical conditions, evaluate organ function, and guide treatment decisions. It is commonly used to image the heart, brain, and bones, among other organs and systems.

Isotope labeling is a scientific technique used in the field of medicine, particularly in molecular biology, chemistry, and pharmacology. It involves replacing one or more atoms in a molecule with a radioactive or stable isotope of the same element. This modified molecule can then be traced and analyzed to study its structure, function, metabolism, or interaction with other molecules within biological systems.

Radioisotope labeling uses unstable radioactive isotopes that emit radiation, allowing for detection and quantification of the labeled molecule using various imaging techniques, such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). This approach is particularly useful in tracking the distribution and metabolism of drugs, hormones, or other biomolecules in living organisms.

Stable isotope labeling, on the other hand, employs non-radioactive isotopes that do not emit radiation. These isotopes have different atomic masses compared to their natural counterparts and can be detected using mass spectrometry. Stable isotope labeling is often used in metabolic studies, protein turnover analysis, or for identifying the origin of specific molecules within complex biological samples.

In summary, isotope labeling is a versatile tool in medical research that enables researchers to investigate various aspects of molecular behavior and interactions within biological systems.

Etidronic acid is a type of medication known as a bisphosphonate. It is used to treat conditions such as Paget's disease, osteoporosis, and certain types of cancer that have spread to the bones.

Etidronic acid works by inhibiting the activity of cells called osteoclasts, which are responsible for breaking down bone tissue. This helps to slow down the process of bone loss and can increase bone density, making bones stronger and less likely to break.

The medication is available in the form of a solution that is given intravenously (through a vein) in a hospital or clinic setting. It may be given as a single dose or as multiple doses over a period of time, depending on the condition being treated and the individual patient's needs.

As with any medication, etidronic acid can have side effects, including nausea, vomiting, diarrhea, and bone pain. It is important for patients to discuss the potential risks and benefits of this medication with their healthcare provider before starting treatment.

Sugar acids are a type of organic acid that are derived from sugars through the process of hydrolysis or oxidation. They have complex structures and can be found in various natural sources such as fruits, vegetables, and honey. In the medical field, sugar acids may be used in the production of pharmaceuticals and other chemical products.

Some common examples of sugar acids include:

* Gluconic acid, which is derived from glucose and has applications in the food industry as a preservative and stabilizer.
* Lactic acid, which is produced by fermentation of carbohydrates and is used in the production of various pharmaceuticals, foods, and cosmetics.
* Citric acid, which is found in citrus fruits and is widely used as a flavoring agent, preservative, and chelating agent in food, beverages, and personal care products.

It's worth noting that while sugar acids have important applications in various industries, they can also contribute to tooth decay and other health problems when consumed in excess. Therefore, it's important to consume them in moderation as part of a balanced diet.

Phosphines are a class of organic compounds characterized by a phosphorus atom bonded to three organic groups and a hydrogen atom, with the general formula of PRR'R''H. They are important in various chemical reactions as reducing agents and catalysts. In medicine, phosphines have no direct medical application. However, certain phosphine compounds have been studied for their potential use as pharmaceuticals, such as phosphinic acids which have shown promise as protease inhibitors used in the treatment of diseases like HIV and HCV. It is important to note that some phosphines are highly toxic and should be handled with care.

I'm sorry for any confusion, but "Rhenium" is not a medical term. It is a chemical element with the symbol "Re" and atomic number 75. Rhenium is a heavy, silvery-white, metallic element that is highly resistant to corrosion and is used in high-temperature alloys and electronics.

It does not have any direct medical relevance or application as a drug, treatment, or diagnostic tool in human medicine. However, like many other elements, rhenium compounds are being studied for their potential medicinal uses, such as in cancer therapy. But it's important to note that these are still in the research phase and have not yet been approved for use in humans.

Tissue distribution, in the context of pharmacology and toxicology, refers to the way that a drug or xenobiotic (a chemical substance found within an organism that is not naturally produced by or expected to be present within that organism) is distributed throughout the body's tissues after administration. It describes how much of the drug or xenobiotic can be found in various tissues and organs, and is influenced by factors such as blood flow, lipid solubility, protein binding, and the permeability of cell membranes. Understanding tissue distribution is important for predicting the potential effects of a drug or toxin on different parts of the body, and for designing drugs with improved safety and efficacy profiles.

Radioimmunodetection (RID) is a medical diagnostic technique that combines the specificity of antibodies with the sensitivity of radioisotopes to detect and locate antigens or tumor markers within the body. This technique involves labeling antibodies with radioactive isotopes, which are then introduced into the patient's body. The labeled antibodies bind to the target antigens, allowing for their detection and localization using external gamma cameras.

The process typically begins with the production of monoclonal or polyclonal antibodies that specifically recognize and bind to a particular antigen associated with a disease or condition. These antibodies are then labeled with radioisotopes such as technetium-99m, iodine-131, or indium-111, which emit gamma rays that can be detected by external imaging devices.

Once the labeled antibodies have been administered to the patient, they circulate throughout the body and bind to their respective antigens. The bound radioactive antibodies can then be imaged using a gamma camera or single-photon emission computed tomography (SPECT) scanner, providing information about the location, size, and distribution of the target antigens within the body.

Radioimmunodetection has been widely used in the detection and monitoring of various malignancies, including cancerous tumors and metastases, as well as inflammatory and infectious diseases. It offers several advantages over other diagnostic techniques, such as high sensitivity, specificity, and non-invasiveness, making it an essential tool in modern medical imaging and diagnostics.

Nitriles, in a medical context, refer to a class of organic compounds that contain a cyano group (-CN) bonded to a carbon atom. They are widely used in the chemical industry and can be found in various materials, including certain plastics and rubber products.

In some cases, nitriles can pose health risks if ingested, inhaled, or come into contact with the skin. Short-term exposure to high levels of nitriles can cause irritation to the eyes, nose, throat, and respiratory tract. Prolonged or repeated exposure may lead to more severe health effects, such as damage to the nervous system, liver, and kidneys.

However, it's worth noting that the medical use of nitriles is not very common. Some nitrile gloves are used in healthcare settings due to their resistance to many chemicals and because they can provide a better barrier against infectious materials compared to latex or vinyl gloves. But beyond this application, nitriles themselves are not typically used as medications or therapeutic agents.

... mertiatide. "Technescan Mag3- technescan tc 99m mertiatide injection, powder, lyophilized, for solution". DailyMed. 13 December ... Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. It is a renal ... Technetium (99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, ... Technetium-99m, Radiopharmaceuticals, All stub articles, Pharmacology stubs). ...
... technetium tc 99m mertiatide MeSH D12.644.456.810 - teprotide MeSH D12.644.456.830 - tetragastrin MeSH D12.644.456.835 - thymic ...
... technetium tc 99m medronate MeSH D02.691.825.775 - technetium tc 99m mertiatide MeSH D02.691.825.875 - technetium tc 99m ... technetium tc 99m disofenin MeSH D02.691.825.562 - technetium tc 99m exametazime MeSH D02.691.825.710 - technetium tc 99m ... technetium tc 99m diethyl-iminodiacetic acid MeSH D02.241.081.583.450 - technetium tc 99m disofenin MeSH D02.241.081.583.900 - ... technetium tc 99m disofenin MeSH D02.491.485.900 - technetium tc 99m lidofenin MeSH D02.491.567.249 - imino furanoses MeSH ...
... mertiatide. "Technescan Mag3- technescan tc 99m mertiatide injection, powder, lyophilized, for solution". DailyMed. 13 December ... Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. It is a renal ... Technetium (99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, ... Technetium-99m, Radiopharmaceuticals, All stub articles, Pharmacology stubs). ...
Technescan Mag3 - Technescan Mag3, also known asTechnetium Tc 99m Mertiatide (Injection Route) ... Technetium Tc 99m Tilmanocept (Injection Route) * Technetium TC 99m TSC - Technetium TC 99m TSC, also known asTechnetium Tc 99m ... Technetium TC 99m TSC - Technetium TC 99m TSC, also known asTechnetium Tc 99m Sulfurcolloid (Injection Route, Route Not ... Technetium Tc 99m Sulfurcolloid (Injection Route, Route Not Applicable) * Technetium Tc 99m Sulfurcolloid (Oral Route, Route ...
Technetium Tc 99m Mertiatide 76% * biocytin 69% * Enzyme Inhibitors 53% * Radionuclide Imaging 44% ... Use of 99mTc-mercaptoacetyltriglycine (MAG3)-biocytin hepatobiliary scintigraphy to study the protective effect of a synthetic ... Dive into the research topics of Use of 99mTc-mercaptoacetyltriglycine (MAG3)-biocytin hepatobiliary scintigraphy to study the ...
Technetium Tc 99m Mertiatide Medicine & Life Sciences 100% * Kidney Medicine & Life Sciences 32% ... A newly developed 99mTc-labeled renal scintigraphic and renographic agent, 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) was ... excretion of 99mTc-MAG3 was slower than that of 131I-OIH and the ratios of T(max), T(2/3) and T( 1/2 ) between 99mTc-MAG3 and ... The highly significant correlations of T(max), T(2/3) and T( 1/2 ) were observed between 99mTc-MAG3 and 131I-OIH with ...
Technetium Tc 99m Mertiatide Medicine & Life Sciences 100% * Multicenter Studies Medicine & Life Sciences 79% ... Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. ... Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. / ... Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. In ...
Technetium Tc-99m disofenin. Technetium Tc-99m disofenin is a radiopharmaceutical agent used in hepatobiliary imaging for ... Matched Products: … Kit for the Preparation of Technetium Tc99m Mertiatide … Milk thistle. Milk thistle is a plant/plant ... Technetium Tc-99m sestamibi. Technetium Tc-99m sestamibi (commonly sestamibi) is a pharmaceutical agent used in nuclear ... Matched Description: … Following intravenous injection of the drug, Technetium Tc-99m sestamibi is taken up by the myocardium ...
Technetium Tc 99m Mertiatide. *Teprotide. *Tetragastrin. *Thymic Factor, Circulating. *Thyrotropin-Releasing Hormone ...
Technetium Tc 99m Lidofenin. *Technetium Tc 99m Medronate. *Technetium Tc 99m Mertiatide ... "Technetium Tc 99m Exametazime" by people in this website by year, and whether "Technetium Tc 99m Exametazime" was a major or ... Technetium Tc 99m Aggregated Albumin. *Technetium Tc 99m Diethyl-iminodiacetic Acid. *Technetium Tc 99m Dimercaptosuccinic Acid ... "Technetium Tc 99m Exametazime" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m ... D4.345.349.810 Technetium Tc 99m Aggregated Albumin D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
Technetium Tc 99m Mertiatide. *Teprotide. *Tetragastrin. *Thymic Factor, Circulating. *Thyrotropin-Releasing Hormone ...
Technetium 99mTc Mertiatide. ©2016 DrugLead US FDA&EMEA. ...
Technetium Tc 99m Mertiatide [D12.644.456.805] * Teprotide [D12.644.456.810] * Tetragastrin [D12.644.456.830] ...
MAG3, TechneScan use Technetium Tc 99m Mertiatide Magainins Magazine use Periodicals as Topic ...
Technetium Tc 99m Mebrofenin. *Technetium Tc 99m Medronate. *Technetium Tc 99m Mertiatide ... Technetium Tc 99m Red Blood Cells. *Technetium Tc 99m Sestamibi. *Technetium Tc 99m Sulfur Colloid ... Technetium Tc 99m Tetrofosmin. *Technetium Tc 99m Tilmanocept. *Technetium Tc 99m White Blood Cells ... Technetium Tc 99m Glucoheptonate. *Technetium Tc 99m Albumin. *Technetium Tc 99m Albumin Aggregated ...
99mTc-Lidofenin use Technetium Tc 99m Lidofenin 99mTc-MAG3 use Technetium Tc 99m Mertiatide ... 99mTc-Diethyl IDA use Technetium Tc 99m Diethyl-iminodiacetic Acid 99mTc-Dimercaptosuccinic Acid use Technetium Tc 99m ... 99mTc-Hexamibi use Technetium Tc 99m Sestamibi ... 99mTc-Sestamibi use Technetium Tc 99m Sestamibi 99Tc-Succimer ... 99mTc-DMSA use Technetium Tc 99m Dimercaptosuccinic Acid ...
99mTc-Lidofenin use Technetium Tc 99m Lidofenin 99mTc-MAG3 use Technetium Tc 99m Mertiatide ... 99mTc-Diethyl IDA use Technetium Tc 99m Diethyl-iminodiacetic Acid 99mTc-Dimercaptosuccinic Acid use Technetium Tc 99m ... 99mTc-Hexamibi use Technetium Tc 99m Sestamibi ... 99mTc-Sestamibi use Technetium Tc 99m Sestamibi 99Tc-Succimer ... 99mTc-DMSA use Technetium Tc 99m Dimercaptosuccinic Acid ...
99mTc-Lidofenin use Technetium Tc 99m Lidofenin 99mTc-MAG3 use Technetium Tc 99m Mertiatide ... 99mTc-Diethyl IDA use Technetium Tc 99m Diethyl-iminodiacetic Acid 99mTc-Dimercaptosuccinic Acid use Technetium Tc 99m ... 99mTc-Hexamibi use Technetium Tc 99m Sestamibi ... 99mTc-Sestamibi use Technetium Tc 99m Sestamibi 99Tc-Succimer ... 99mTc-DMSA use Technetium Tc 99m Dimercaptosuccinic Acid ...
Technetium-99m 43. 56. 6 hr. γ,IC. 141 Synthetic. most commonly used medical radioisotope, used as a radioactive tracer ... 99mTc (Mertiatide, Pentetic acid). Gastrointestinal/Hepatic. *75Se (SeHCAT). Respiratory system. *133Xe ... Technetium-99m 1.95×107 TBq/kg (5.27 × 105 Ci/g) 6 hours 140 ... A typical example is the technetium-99m generator used in ... Technetium-99 43. 56. 210,000 y. β−. 294 Fission product. most common isotope of the lightest unstable element, most ...
99mTc (Mertiatide, Pentetic acid). Gastrointestinal/Hepatic. *75Se (SeHCAT). Respiratory system. *133Xe ...
Tc-99m DTPA acetylsalicylic acid (aspirin) renography in the detection of renovascular hypertension. Clin Nucl Med. 2000 Sep. ... Technetium-labeled mertiatide (MAG3) has also been used. Since the introduction of captopril renography, various modifications ... For RAS greater than 50%, Tc-MAG3-captopril renography has a sensitivity of 90%, a specificity of 91%, a positive predictive ... Radionuclide renography with technetium-mercaptoacetyltriglycine (MAG3)-captopril has a high sensitivity and specificity and ...
Technetium-99m Medronate (MDP-25): Bone Imaging and Osteogenesis Evaluation. *Technetium-99m Mertiatide: A Gold Standard ... Diagnostic Potential of Technetium-99m Macroaggregated Albumin (Tc-99m MAA) in Hepatobiliary Imaging ... Technetium-99m Oxidronate (Technescan HDP) for Bone Imaging. *Technetium-99m Pentetate in Diagnostic Imaging: A Closer Look at ... Technetium-99m Pyrophosphate (Technescan PYP) in Bone Imaging and Cardiac Imaging. *Technetium-99m Sestamibi in Cardiac ...
  • abstract = "PURPOSE: To evaluate an improved camera-based method for calculating the clearance of technetium-99m mercaptoacetyltriglycine (MAG3) in a multicenter trial. (elsevierpure.com)
  • MATERIALS AND METHODS: Tc-99m MAG 3 scintigraphy was performed in 49 patients at three sites in the United States and Canada. (elsevierpure.com)
  • The active ingredient, betiatide, is reconstituted with sodium pertechnetate 99mTc injection to form technetium (99mTc) mertiatide. (wikipedia.org)
  • The percentage of the injected dose of Tc-99m MAG 3 in the kidney at 1-2, 1.0-2.5, and 2-3 minutes after injection was correlated with the plasma-based Tc-99m MAG 3 clearances. (elsevierpure.com)
  • Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. (wikipedia.org)
  • Tc 99m MAG3) as a diagnostic agent. (nih.gov)
  • 1 ] The effective half-life of Tc 99m MAG3 averages 4.2 hours (range 3.6 to 4.9 hours) and 0.073% of an administered dose appears in breastmilk. (nih.gov)
  • Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. (wikipedia.org)
  • Technetium (99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi. (wikipedia.org)
  • The active ingredient, betiatide, is reconstituted with sodium pertechnetate 99mTc injection to form technetium (99mTc) mertiatide. (wikipedia.org)
  • Technetium Tc 99m Pentetate. (nih.gov)
  • A technetium diagnostic aid used in renal function determination. (nih.gov)
  • For nursing mothers who work with Tc 99m substances in their workplace, there is no need to take any precautions other than those appropriate for general radiation protection. (nih.gov)
  • A US Nuclear Regulatory Commission subcommittee has recommended that nursing be discontinued for 24 hours after administration of all technetium Tc 99m diagnostic products to simplify guidance recommendations, although this time interval may be longer than necessary. (nih.gov)

No images available that match "technetium tc 99m mertiatide"